Bertacchini et al. [39] investigated 80 samples of primary cells from AML patients and found that inhibition of Akt and mTOR resulted in paradoxical activation of growth factor receptor tyrosine kinases (RTKs). Here, AKT1 is linked to acute myeloid leukemia.